Oxford Asset Management »

Astria Therapeutics shares owned by Oxford Asset Management

Quarter-by-quarter ownership of Astria Therapeutics shares owned by Oxford Asset Management from 13F filings

Historical chart of Oxford Asset Management investment in Astria Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Astria Therapeutics held by Oxford Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Astria Therapeutics by Oxford Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $687k 53k 13.09

More positions owned by Oxford Asset Management

Spdr Series Trust State Street Spd (XBI)
Netflix (NFLX)
Marvell Technology (MRVL)
Boeing Company (BA)
Micron Technology (MU)
Nordson Corporation (NDSN)
Jamf Hldg Corp
Denny's Corporation
UnitedHealth (UNH)
Sherwin-Williams Company (SHW)
Kroger (KR)
EOG Resources (EOG)
Cidara Therapeutics Com New (CDTX)
Citigroup Com New (C)
Maximus (MMS)

View all positions for Oxford Asset Management

Top funds holding Astria Therapeutics

Perceptive Advisors
FMR
BlackRock
Glazer Capital
Millennium Management
Vanguard Group
UBS Group
Deutsche Bank Aktiengesellschaft
Jpmorgan Chase & Co
Driehaus Capital Management
Geode Capital Management
Nantahala Capital Management
Qube Research & Technologies
Omni Event Management
Man Group

View all funds holding Astria Therapeutics